Preclinical evaluation of antigen-specific nanotherapy based on phosphatidylserine-liposomes for type 1 diabetes

Autor: Villalba A, Rodriguez-Fernandez S, Ampudia RM, Cano-Sarabia M, Perna-Barrull D, Bertran-Cobo C, Ehrenberg C, Maspoch D, Vives-Pi M

Publikováno v: Artificial Cells, Nanomedicine, And Biotechnology
r-IGTP: Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Universidad de Alicante (UA)

Type 1 diabetes (T1D) is an autoimmune disease caused by the destruction of insulin-producing cells. Due to the ability of apoptotic cells clearance to induce tolerance, we previously generated liposomes rich in phophatidylserine (PS) -a feature of a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ae86064549eee054ae6a190100e081d4
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1175

Corrigendum: NK cell subsets changes in partial remission and early stages of pediatric type 1 diabetes.

Autor: Gomez-Muñoz L; Immunology Service, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain., Perna-Barrull D; Immunology Service, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain., Villalba A; Immunology Service, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain., Rodriguez-Fernandez S; Immunology Service, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain., Ampudia RM; Immunology Service, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain., Teniente-Serra A; Immunology Service, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain., Vazquez F; Endocrinology Service, Germans Trias i Pujol University Hospital, Badalona, Spain., Murillo M; Pediatrics Service, Germans Trias i Pujol University Hospital, Badalona, Spain., Perez J; Department of Pediatric Endocrine, Parc Tauli Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí I3PT, Universitat Autonoma de Barcelona, Sabadell, Spain., Corripio R; Department of Pediatric Endocrine, Parc Tauli Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí I3PT, Universitat Autonoma de Barcelona, Sabadell, Spain., Bel J; Pediatrics Service, Germans Trias i Pujol University Hospital, Badalona, Spain., Vives-Pi M; Immunology Service, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 Jun 05; Vol. 15, pp. 1439246. Date of Electronic Publication: 2024 Jun 05 (Print Publication: 2024).

Antigen-specific immunotherapy combined with a regenerative drug in the treatment of experimental type 1 diabetes.

Autor: Villalba A; Immunology Section, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Carretera Canyet s/n, 08916, Badalona, Spain., Rodriguez-Fernandez S; Immunology Section, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Carretera Canyet s/n, 08916, Badalona, Spain., Perna-Barrull D; Immunology Section, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Carretera Canyet s/n, 08916, Badalona, Spain., Ampudia RM; Immunology Section, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Carretera Canyet s/n, 08916, Badalona, Spain., Gomez-Muñoz L; Immunology Section, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Carretera Canyet s/n, 08916, Badalona, Spain., Pujol-Autonell I; Immunology Section, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Carretera Canyet s/n, 08916, Badalona, Spain., Aguilera E; Endocrinology Section, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain., Risueño RM; Josep Carreras Leukaemia Research Institute, Campus GTP-ICO, Badalona, Spain., Cano-Sarabia M; Catalan Institute of Nanoscience and Nanotechnology, CSIC, The Barcelona Institute of Science and Technology, Bellaterra, Spain., Maspoch D; Catalan Institute of Nanoscience and Nanotechnology, CSIC, The Barcelona Institute of Science and Technology, Bellaterra, Spain.; ICREA, Pg. Lluís Companys 23, 08010, Barcelona, Spain., Vázquez F; Endocrinology Section, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain., Vives-Pi M; Immunology Section, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Carretera Canyet s/n, 08916, Badalona, Spain. mvives@igtp.cat.

Publikováno v: Scientific reports [Sci Rep] 2020 Nov 03; Vol. 10 (1), pp. 18927. Date of Electronic Publication: 2020 Nov 03.

Partial remission and early stages of pediatric type 1 diabetes display immunoregulatory changes. A pilot study.

Autor: Villalba A; Immunology Section, Germans Trias i Pujol Research Institute, Badalona, Spain., Fonolleda M; Immunology Section, Germans Trias i Pujol Research Institute, Badalona, Spain., Murillo M; Pediatrics Section, Germans Trias i Pujol Research Institute and University Hospital, Autonomous University of Barcelona, Badalona, Spain., Rodriguez-Fernandez S; Immunology Section, Germans Trias i Pujol Research Institute, Badalona, Spain., Ampudia RM; Immunology Section, Germans Trias i Pujol Research Institute, Badalona, Spain., Perna-Barrull D; Immunology Section, Germans Trias i Pujol Research Institute, Badalona, Spain., Raina MB; Pediatrics Section, Germans Trias i Pujol Research Institute and University Hospital, Autonomous University of Barcelona, Badalona, Spain., Quirant-Sanchez B; Immunology Section, Germans Trias i Pujol Research Institute, Badalona, Spain., Planas R; Immunology Section, Germans Trias i Pujol Research Institute, Badalona, Spain., Teniente-Serra A; Immunology Section, Germans Trias i Pujol Research Institute, Badalona, Spain., Bel J; Pediatrics Section, Germans Trias i Pujol Research Institute and University Hospital, Autonomous University of Barcelona, Badalona, Spain., Vives-Pi M; Immunology Section, Germans Trias i Pujol Research Institute, Badalona, Spain; CIBER of Diabetes and Associated Metabolic Disease (CIBERDEM). ISCIII, Barcelona, Spain. Electronic address: mvives@igtp.cat.

Publikováno v: Translational research : the journal of laboratory and clinical medicine [Transl Res] 2019 Aug; Vol. 210, pp. 8-25. Date of Electronic Publication: 2019 Mar 15.

The G1/S Specific Cyclin D2 Is a Regulator of HIV-1 Restriction in Non-proliferating Cells.

Autor: Badia R; AIDS Research Institute-IrsiCaixa, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.; Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain., Pujantell M; AIDS Research Institute-IrsiCaixa, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.; Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain., Riveira-Muñoz E; AIDS Research Institute-IrsiCaixa, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.; Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain., Puig T; AIDS Research Institute-IrsiCaixa, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.; Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain., Torres-Torronteras J; Research Group on Neuromuscular and Mitochondrial Disorders, Vall d'Hebron Institut de Recerca, Universitat Autònoma de Barcelona, and Biomedical Network Research Centre on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain., Martí R; Research Group on Neuromuscular and Mitochondrial Disorders, Vall d'Hebron Institut de Recerca, Universitat Autònoma de Barcelona, and Biomedical Network Research Centre on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain., Clotet B; AIDS Research Institute-IrsiCaixa, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.; Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain., Ampudia RM; Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.; Biomedical Network Research Centre on Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain., Vives-Pi M; Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.; Biomedical Network Research Centre on Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain., Esté JA; AIDS Research Institute-IrsiCaixa, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.; Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain., Ballana E; AIDS Research Institute-IrsiCaixa, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.; Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.

Publikováno v: PLoS pathogens [PLoS Pathog] 2016 Aug 19; Vol. 12 (8), pp. e1005829. Date of Electronic Publication: 2016 Aug 19 (Print Publication: 2016).